
    
      Considering that there are potential advantages to once-daily depakote extended release in
      terms of decreased side effects, decreased medication errors and patient compliance, there is
      a need to determine the best method of conversion from multiple-daily dose delayed release
      depakote to once-daily for subjects with epilepsy bipolar disorder or behavior disorders.
    
  